Lambe Jeffrey, Fitzgerald Kathryn C, Murphy Olwen C, Filippatou Angeliki G, Sotirchos Elias S, Kalaitzidis Grigorios, Vasileiou Elena, Pellegrini Nicole, Ogbuokiri Esther, Toliver Brandon, Luciano Nicholas J, Davis Simidele, Fioravante Nicholas, Kwakyi Ohemaa, Risher Hunter, Crainiceanu Ciprian M, Prince Jerry L, Newsome Scott D, Mowry Ellen M, Saidha Shiv, Calabresi Peter A
From the Department of Neurology (J.L., K.C.F., O.C.M., A.G.F., E.S.S., G.K., E.V., N.P., E.O., B.T., N.J.L., S.D., N.F., O.K., H.R., S.D.N., E.M.M., S.S., P.A.C.), Johns Hopkins University School of Medicine; and Departments of Biostatistics (C.M.C.) and Electrical and Computer Engineering (J.L.P.), Johns Hopkins University, Baltimore, MD.
Neurology. 2021 Apr 20;96(16):e2058-e2069. doi: 10.1212/WNL.0000000000011788. Epub 2021 Mar 2.
To evaluate whether a retinal spectral-domain optical coherence tomography (SD-OCT) assessment at baseline is associated with long-term disability worsening in people with multiple sclerosis (PwMS), we performed SD-OCT and Expanded Disability Status Scale (EDSS) assessments among 132 PwMS at baseline and at a median of 10 years later.
In this prospective, longitudinal study, participants underwent SD-OCT, EDSS, and visual acuity (VA) assessments at baseline and at follow-up. Statistical analyses were performed using generalized linear regression models, adjusted for age, sex, race, multiple sclerosis (MS) subtype, and baseline disability. We defined clinically meaningful EDSS worsening as an increase of ≥2.0 if baseline EDSS score was <6.0 or an increase of ≥1.0 if baseline EDSS score was ≥6.0.
A total of 132 PwMS (mean age 43 years; 106 patients with relapsing-remitting MS) were included in analyses. Median duration of follow-up was 10.4 years. In multivariable models excluding eyes with prior optic neuritis, relative to patients with an average baseline ganglion cell + inner plexiform layer (GCIPL) thickness ≥70 µm (the mean GCIPL thickness of all eyes at baseline), an average baseline GCIPL thickness <70 µm was associated with a 4-fold increased odds of meaningful EDSS worsening (adjusted odds ratio [OR] 3.97, 95% confidence interval [CI] 1.24-12.70; = 0.02) and an almost 3-fold increased odds of low-contrast VA worsening (adjusted OR 2.93, 95% CI 1.40-6.13; = 0.04).
Lower baseline GCIPL thickness on SD-OCT is independently associated with long-term disability worsening in MS. Accordingly, SD-OCT at a single time point may help guide therapeutic decision-making among individual PwMS.
This study provides Class I evidence that lower baseline GCIPL thickness on SD-OCT is independently associated with long-term disability worsening in MS.
为评估基线时的视网膜光谱域光学相干断层扫描(SD-OCT)评估是否与多发性硬化症(PwMS)患者的长期残疾恶化相关,我们在132例PwMS患者基线时以及中位时间10年后进行了SD-OCT和扩展残疾状态量表(EDSS)评估。
在这项前瞻性纵向研究中,参与者在基线和随访时接受了SD-OCT、EDSS和视力(VA)评估。使用广义线性回归模型进行统计分析,并对年龄、性别、种族、多发性硬化症(MS)亚型和基线残疾进行了调整。如果基线EDSS评分<6.0,我们将临床上有意义的EDSS恶化定义为增加≥2.0;如果基线EDSS评分≥6.0,则定义为增加≥1.0。
共有132例PwMS(平均年龄43岁;106例复发缓解型MS患者)纳入分析。中位随访时间为10.4年。在排除既往有视神经炎的眼睛的多变量模型中,相对于基线时神经节细胞+内丛状层(GCIPL)平均厚度≥70 µm的患者(所有眼睛在基线时的平均GCIPL厚度),基线时平均GCIPL厚度<70 µm与有意义的EDSS恶化几率增加4倍相关(调整后的优势比[OR] 3.97,95%置信区间[CI] 1.24 - 12.70;P = 0.02),以及低对比度VA恶化几率增加近3倍相关(调整后的OR 2.93,95% CI 1.40 - 6.13;P = 0.04)。
SD-OCT上较低的基线GCIPL厚度与MS患者的长期残疾恶化独立相关。因此,单次SD-OCT检查可能有助于指导个体PwMS患者的治疗决策。
本研究提供了I类证据,表明SD-OCT上较低的基线GCIPL厚度与MS患者的长期残疾恶化独立相关。